Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-05-12 | Amended | $6,499,590 | $1,294,000 | Debt Only | 06b | SEC link |
| 2024-10-03 | New | $5,205,590 | $5,205,590 | Debt Only | 06b | SEC link |
| Name | Role |
|---|---|
| John Beaver | Director, Executive |
| Jack Hoppin | Director |
| Karl Schmidt | Executive |
| Kenan Turnacioglu | Director, Executive |